Avecho Biotechnology Limited has released a press release.
Avecho enters final stage of Phase III insomnia trial
Earlier from Avecho Biotechnology
- June 2026 Quarterly Activities Report & Appendix 4C
- Positive interim analysis advances Avecho Phase III insomnia program
- Positive interim results from Phase III insomnia program
- Receipt of Research & Development Tax Incentive